Toll Access
Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative patients are transfused with D-positive random donor platelets
Clinton A. Ewing/ Dawn H. Rumsey/ Albert F. Langeberg/ S. Gerald Sandler
DOI: 10.21307/immunohematology-2019-680